{
    "Trade/Device Name(s)": [
        "Vantera\u00ae Clinical Analyzer",
        "NMR LipoProfile\u00ae test on Vantera\u00ae Clinical Analyzer"
    ],
    "Submitter Information": "LipoScience, Inc.",
    "510(k) Number": "K113830",
    "Predicate Device Reference 510(k) Number(s)": [
        "K111516",
        "K073506"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NSU",
        "MRR",
        "LBS",
        "CDT"
    ],
    "Summary Letter Date": "July 27, 2012",
    "Summary Letter Received Date": "July 30, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.2570",
        "21 CFR 862.1475",
        "21 CFR 862.1175",
        "21 CFR 862.1705"
    ],
    "Regulation Name(s)": [
        "Instrumentation for clinical multiplex test system",
        "Lipoprotein test system",
        "Cholesterol test system",
        "Triglyceride test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "tdm",
        "toxicology"
    ],
    "Analyte(s)": [
        "LDL particle number (LDL-P)",
        "HDL cholesterol (HDL-C)",
        "Triglycerides"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Lipotube"
    ],
    "Instrument(s)/Platform(s)": [
        "Vantera\u00ae Clinical Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Nuclear magnetic resonance (NMR) spectroscopy"
    ],
    "Methodologies": [
        "Spectral deconvolution analysis",
        "Linear least-squares with singular value decomposition"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Assay",
        "Calibrator",
        "Quality control material",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Vantera Clinical Analyzer and NMR LipoProfile test for measuring LDL particle number, HDL cholesterol, and triglycerides in serum and plasma via NMR spectroscopy",
    "Indications for Use Summary": "Automated analyzer and NMR LipoProfile test for quantifying LDL particle number, HDL cholesterol, and triglycerides in human serum and plasma to aid in managing lipoprotein disorders related to cardiovascular disease",
    "fda_folder": "Clinical Chemistry"
}